2-methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-thiadiazole
Structure Info
- Chemspace ID
- CSSB03555198603 (In-Stock Building Blocks)
- CAS
- 2396463-89-9
- IUPAC Name
- 2-methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-thiadiazole
- Mol formula
- C15H19BN2O2S
- Mol weight
- 302 Da
- Catalog Number(s)
- BBLS03555198603, BBV-398185066, EN300-34772129, a6_52846_35781, bbls03555198603
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.39
- Heavy atoms count
- 21
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.466
- Polar surface area (Å)
- 44
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 0
- Zoom the structure
- CSSB03555198603
Items Overall 14 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 50 mg | 153.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 100 mg | 228.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 250 mg | 325.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 500 mg | 512.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 1 g | 656.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 2.5 g | 1,287.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 5 g | 1,903.00 | |
| Enamine Ltd. | 5 days | Ukraine To: | 95 | 10 g | 2,823.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 50 mg | 153.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 100 mg | 228.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 250 mg | 325.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 500 mg | 512.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 1 g | 656.00 | |
| Enamine US, Inc. | 5 days | United States To: | 95 | 2.5 g | 1,287.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-thiadiazol-2-amine - CSSB00010171905](/st/structure/200/17da10558aacb0d2fc2dee6f7b5b0696/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C1%253DNN%253DC%2528N%2529S1.png)

![Chemical structure of 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-thiadiazole - CSSB03552306896](/st/structure/200/0c693a6cfddce806a10089813ad0c1c5/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2ccc%2528cc2%2529c3nncs3.png)
![Chemical structure of 4,4,5,5-tetramethyl-2-{4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]phenyl}-1,3,2-dioxaborolane - CSSB15352318108](/st/structure/200/132050882e71f64b94b9b025afb69206/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1%2529C%2528%253DO%2529C1%253DCC%253DC%2528C%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
![Chemical structure of 2-methyl-5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3,4-oxadiazole - CSSB00010144811](/st/structure/200/8c3ddbce958b5166652338b9aa5b6d09/CC1%253DNN%253DC%2528O1%2529C1%253DCC%253DC%2528C%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)

![Chemical structure of 2-methyl-4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-thiazole - CSSB00010187453](/st/structure/200/028e31e368a0d8f571ce4943cb26446c/CC1%253DNC%2528%253DCS1%2529C1%253DCC%253DC%2528C%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
